MYD88 and diffuse large B-cell lymphoma: Previous research has shown that high expression of PIM3 is a poor prognostic factor for DLBCL patients and is associated with common mutated genes in DLBCL, such as MYD88, MYC, and BTK (Wang et al., 2023).